DermTech Inc. (DMTK) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
12340 EL CAMINO REAL SAN DIEGO, CA 92130 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 3/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 55,864 | 126,168 | 225,331 | 63,777 | 15,374 | 30 | |||
| Cash and cash equivalents | 36,741 | 77,757 | 176,882 | 24,248 | 15,374 | 30 | |||
| Short-term investments | 19,123 | 48,411 | 48,449 | 39,529 | |||||
| Receivables | 2,584 | 4,172 | 3,847 | 1,480 | 680 | ||||
| Inventory, net of allowances, customer advances and progress billings | 1,004 | 1,757 | 480 | 104 | 35 | ||||
| Inventory | 1,004 | 1,757 | 480 | 104 | 35 | ||||
| Prepaid expense | 1,285 | 1,801 | 1,172 | 951 | 51 | ||||
| Deferred costs | 56 | ||||||||
| Other current assets | 581 | 733 | 136 | 79 | 25 | ||||
| Other undisclosed current assets | 1,719 | 1,922 | 1,229 | 214 | 85 | ||||
| Total current assets: | 61,752 | 136,037 | 232,824 | 66,882 | 17,150 | 82 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 51,722 | 56,007 | 7,744 | ✕ | |||||
| Property, plant and equipment | 4,988 | 6,375 | 4,549 | 2,731 | 977 | ||||
| Asset, held-in-trust | 12,358 | ||||||||
| Restricted cash and investments | 3,468 | 3,025 | |||||||
| Other noncurrent assets | 168 | 167 | 167 | 84 | |||||
| Other undisclosed noncurrent assets | 3,488 | ||||||||
| Total noncurrent assets: | 60,178 | 66,038 | 15,485 | 2,898 | 1,061 | 12,358 | |||
| TOTAL ASSETS: | 121,930 | 202,075 | 248,309 | 69,780 | 18,211 | 12,440 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 3,501 | 5,883 | 9,227 | 4,411 | 2,969 | 1,522 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 5,120 | 2,075 | 1,142 | |||
| Accounts payable | 1,484 | 2,419 | 2,880 | 1,573 | 1,609 | ||||
| Accrued liabilities | 2,017 | 3,464 | 1,227 | 763 | 218 | ||||
| Other undisclosed accounts payable and accrued liabilities | 1,522 | ||||||||
| Deferred revenue | 196 | 109 | 1,380 | 905 | 1,390 | ✕ | |||
| Debt | 17 | 116 | 121 | 109 | |||||
| Due to related parties | ✕ | ✕ | 36 | ||||||
| Other undisclosed current liabilities | 9,733 | 9,528 | 1,453 | 1,363 | |||||
| Total current liabilities: | 13,447 | 15,636 | 12,181 | 5,425 | 5,722 | 1,558 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 38 | 53 | 6,284 | 226 | |||||
| Finance lease, liability | 38 | 53 | 136 | 226 | ✕ | ||||
| Liabilities, other than long-term debt | 51,270 | 54,028 | 639 | ||||||
| Deferred revenue | 639 | ✕ | |||||||
| Operating lease, liability | 51,270 | 54,028 | 6,148 | ✕ | |||||
| Other undisclosed noncurrent liabilities | 5 | (6,002) | 5,031 | ||||||
| Total noncurrent liabilities: | 51,308 | 54,086 | 6,430 | 865 | 5,031 | ||||
| Total liabilities: | 64,755 | 69,722 | 18,611 | 6,290 | 5,722 | 6,590 | |||
| Temporary equity, carrying amount | 850 | ||||||||
| Equity | |||||||||
| Equity, attributable to parent | 57,175 | 132,353 | 229,698 | 63,490 | 12,489 | 5,000 | |||
| Common stock | 3 | 3 | 3 | 2 | 1 | 3,202 | |||
| Additional paid in capital | 480,929 | 456,171 | 436,183 | 189,849 | 103,599 | ||||
| Accumulated other comprehensive income (loss) | 178 | (774) | (124) | (1) | |||||
| Retained earnings (accumulated deficit) | (423,935) | (323,047) | (206,364) | (126,360) | (91,111) | 1,798 | |||
| Total equity: | 57,175 | 132,353 | 229,698 | 63,490 | 12,489 | 5,000 | |||
| TOTAL LIABILITIES AND EQUITY: | 121,930 | 202,075 | 248,309 | 69,780 | 18,211 | 12,440 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 3/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 15,296 | 14,518 | 11,838 | 5,885 | 3,364 | |||
| Cost of revenue | (15,020) | (13,871) | (10,564) | (5,981) | (3,304) | |||
| Gross profit: | 276 | 647 | 1,274 | (96) | 60 | |||
| Operating expenses | (104,015) | (118,812) | (78,672) | (35,193) | (17,665) | (1,978) | ||
| Operating loss: | (103,739) | (118,165) | (77,398) | (35,289) | (17,605) | (1,978) | ||
| Nonoperating income (expense) | 2,851 | 1,482 | (937) | 40 | (2,084) | 2,863 | ||
| Investment income, nonoperating | 2,863 | |||||||
| Other nonoperating expense | (355) | |||||||
| Interest and debt expense | (5) | (13) | (17) | 928 | ||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | ||||||||
| Income (loss) from continuing operations: | (100,893) | (116,696) | (78,352) | (35,249) | (18,761) | 885 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (78,352) | (35,249) | (18,761) | 885 | |
| Other undisclosed net income (loss) | 5 | 13 | 17 | (928) | ||||
| Net income (loss): | (100,888) | (116,683) | (78,335) | (35,249) | (19,689) | 885 | ||
| Other undisclosed net income attributable to parent | 59 | |||||||
| Net income (loss) available to common stockholders, basic: | (100,888) | (116,683) | (78,335) | (35,249) | (19,689) | 944 | ||
| Dilutive securities, effect on basic earnings per share | (201) | |||||||
| Net income (loss) available to common stockholders, diluted: | (100,888) | (116,683) | (78,335) | (35,249) | (19,689) | 743 | ||
Comprehensive Income ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 3/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (100,888) | (116,683) | (78,335) | (35,249) | (19,689) | 885 | ||
| Comprehensive income (loss): | (100,888) | (116,683) | (78,335) | (35,249) | (19,689) | 885 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 952 | (650) | (123) | (1) | ||||
| Comprehensive income (loss), net of tax, attributable to parent: | (99,936) | (117,333) | (78,458) | (35,250) | (19,689) | 885 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.